Literature DB >> 27373608

Pathogenesis of Alcoholic Liver Disease.

Winston Dunn1, Vijay H Shah2.   

Abstract

Alcoholic liver disease includes a broad clinical-histological spectrum from simple steatosis, cirrhosis, acute alcoholic hepatitis with or without cirrhosis to hepatocellular carcinoma as a complication of cirrhosis. The pathogenesis of alcoholic liver disease can be conceptually divided into (1) ethanol-mediated liver injury, (2) inflammatory immune response to injury, (3) intestinal permeability and microbiome changes. Corticosteroids may improve outcomes, but this is controversial and probably only impacts short-term survival. New pathophysiology-based therapies are under study, including antibiotics, caspase inhibition, interleukin-22, anakinra, FXR agonist and others. These studies provide hope for better future outcomes for this difficult disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcoholic hepatitis; Alcoholic liver disease; Corticosteroids; Intestinal permeability; Microbiome; Sterile necrosis

Mesh:

Year:  2016        PMID: 27373608      PMCID: PMC4933837          DOI: 10.1016/j.cld.2016.02.004

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  60 in total

1.  Steatohepatitis induced by intragastric overfeeding in mice.

Authors:  Qing-Gao Deng; Hongyun She; Jason H Cheng; Samuel W French; Dennis R Koop; Shigang Xiong; Hidekazu Tsukamoto
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

2.  Alcoholic liver disease patients treated with S-adenosyl-L-methionine: an in-depth look at liver morphologic data comparing pre and post treatment liver biopsies.

Authors:  Mary D Le; Elena Enbom; Peter K Traum; Valentina Medici; Charles H Halsted; Samuel W French
Journal:  Exp Mol Pathol       Date:  2013-07-23       Impact factor: 3.362

3.  Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice.

Authors:  Raul Lazaro; Raymond Wu; Sunyoung Lee; Nian-Ling Zhu; Chia-Lin Chen; Samuel W French; Jun Xu; Keigo Machida; Hidekazu Tsukamoto
Journal:  Hepatology       Date:  2014-11-25       Impact factor: 17.425

4.  Regulation of FOXO3 by phosphorylation and methylation in hepatitis C virus infection and alcohol exposure.

Authors:  Irina Tikhanovich; Sudhakiranmayi Kuravi; Roosevelt V Campbell; Kusum K Kharbanda; Antonio Artigues; Maria T Villar; Steven A Weinman
Journal:  Hepatology       Date:  2013-11-20       Impact factor: 17.425

5.  Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis.

Authors:  Wei Zhong; Yantao Zhao; Yunan Tang; Xiaoli Wei; Xue Shi; Wenlong Sun; Xiuhua Sun; Xinmin Yin; Xinguo Sun; Seongho Kim; Craig J McClain; Xiang Zhang; Zhanxiang Zhou
Journal:  Am J Pathol       Date:  2012-01-09       Impact factor: 4.307

6.  Increased 4-hydroxynonenal protein adducts in male GSTA4-4/PPAR-α double knockout mice enhance injury during early stages of alcoholic liver disease.

Authors:  Martin J J Ronis; Kelly E Mercer; Brenda Gannon; Bridgette Engi; Piotr Zimniak; Colin T Shearn; David J Orlicky; Emanuele Albano; Thomas M Badger; Dennis R Petersen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-11       Impact factor: 4.052

7.  Critical role of FoxO3a in alcohol-induced autophagy and hepatotoxicity.

Authors:  Hong-Min Ni; Kuo Du; Min You; Wen-Xing Ding
Journal:  Am J Pathol       Date:  2013-10-01       Impact factor: 4.307

Review 8.  Functions of autophagy in normal and diseased liver.

Authors:  Mark J Czaja; Wen-Xing Ding; Terrence M Donohue; Scott L Friedman; Jae-Sung Kim; Masaaki Komatsu; John J Lemasters; Antoinette Lemoine; Jiandie D Lin; Jing-hsiung James Ou; David H Perlmutter; Glenn Randall; Ratna B Ray; Allan Tsung; Xiao-Ming Yin
Journal:  Autophagy       Date:  2013-05-22       Impact factor: 16.016

9.  Build a better mouse model, and the world will beat a path to your door.

Authors:  Gavin E Arteel
Journal:  Hepatology       Date:  2013-09-13       Impact factor: 17.425

Review 10.  Review article: the diagnosis and management of alcoholic hepatitis.

Authors:  S M Cohen; J Ahn
Journal:  Aliment Pharmacol Ther       Date:  2009-03-26       Impact factor: 8.171

View more
  40 in total

1.  MicroRNA-200a induces apoptosis by targeting ZEB2 in alcoholic liver disease.

Authors:  Yu-Xin Zhao; Ying-Yin Sun; Ai-Ling Huang; Xiao-Feng Li; Cheng Huang; Tao-Tao Ma; Jun Li
Journal:  Cell Cycle       Date:  2018-01-15       Impact factor: 4.534

Review 2.  New paradigms in management of alcoholic hepatitis: a review.

Authors:  Sandeep Singh Sidhu; Omesh Goyal; Harsh Kishore; Simran Sidhu
Journal:  Hepatol Int       Date:  2017-02-28       Impact factor: 6.047

3.  Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.

Authors:  Takayuki Koga; Pei-Li Yao; Maryam Goudarzi; Iain A Murray; Gayathri Balandaram; Frank J Gonzalez; Gary H Perdew; Albert J Fornace; Jeffrey M Peters
Journal:  J Biol Chem       Date:  2016-10-20       Impact factor: 5.157

Review 4.  Alcoholic liver disease: a new insight into the pathogenesis of liver disease.

Authors:  Seol Hee Park; Young-Sun Lee; Jaemin Sim; Seonkyung Seo; Wonhyo Seo
Journal:  Arch Pharm Res       Date:  2022-06-27       Impact factor: 6.010

Review 5.  The Beneficial Effects of Natural Extracts and Bioactive Compounds on the Gut-Liver Axis: A Promising Intervention for Alcoholic Liver Disease.

Authors:  Liang Zhao; Shaoxuan Wang; Nanhai Zhang; Jingxuan Zhou; Arshad Mehmood; Rifat Nowshin Raka; Feng Zhou; Lei Zhao
Journal:  Antioxidants (Basel)       Date:  2022-06-20

Review 6.  Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease.

Authors:  Dongqing Wu; Huaqing Zhu; Hua Wang
Journal:  Front Physiol       Date:  2021-07-14       Impact factor: 4.566

7.  Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12.

Authors:  Juan P Arab; Daniel Cabrera; Tejasav S Sehrawat; Nidhi Jalan-Sakrikar; Vikas K Verma; Douglas Simonetto; Sheng Cao; Usman Yaqoob; Jonathan Leon; Mariela Freire; Jose I Vargas; Thiago M De Assuncao; Jung H Kwon; Yi Guo; Enis Kostallari; Qing Cai; Tatiana Kisseleva; Youngman Oh; Marco Arrese; Robert C Huebert; Vijay H Shah
Journal:  J Hepatol       Date:  2020-02-20       Impact factor: 25.083

8.  The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in mice.

Authors:  Huikuan Chu; Lu Jiang; Bei Gao; Nagsen Gautam; Jawaher A Alamoudi; Sonja Lang; Yanhan Wang; Yi Duan; Yazen Alnouti; Edward E Cable; Bernd Schnabl
Journal:  Transl Res       Date:  2020-06-15       Impact factor: 7.012

9.  Aqueous Mulberry Leaf Extract Ameliorates Alcoholic Liver Injury Associating with Upregulation of Ethanol Metabolism and Suppression of Hepatic Lipogenesis.

Authors:  Yi-Ju Lee; Ming-Chang Tsai; Hui-Ting Lin; Chau-Jong Wang; Shao-Hsuan Kao
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-08       Impact factor: 2.629

10.  Effect of Lactobacillus casei on lipid metabolism and intestinal microflora in patients with alcoholic liver injury.

Authors:  Xuelong Li; Ying Liu; Xiaofei Guo; Yan Ma; Huaqi Zhang; Hui Liang
Journal:  Eur J Clin Nutr       Date:  2021-01-29       Impact factor: 4.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.